Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Zynerba Pharmaceuticals, Inc. | Director | Common Stock | 0 | $1.33 | Oct 10, 2023 | Direct | |
Zynerba Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | Oct 10, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ZYNE | Zynerba Pharmaceuticals, Inc. | Oct 10, 2023 | 4 | $0 | 4 | Oct 11, 2023 | Director |
ZYNE | Zynerba Pharmaceuticals, Inc. | Jun 13, 2023 | 3 | -$40 | 4 | Jun 15, 2023 | Director |
ZYNE | Zynerba Pharmaceuticals, Inc. | Jun 14, 2022 | 3 | -$40 | 4 | Jun 16, 2022 | Director |
ZYNE | Zynerba Pharmaceuticals, Inc. | Aug 3, 2021 | 2 | $0 | 4 | Aug 5, 2021 | Director |